Joshi Ramanjulu is the Chief Scientific Officer at Apogee Pharma, leveraging nearly 26 years of experience from GSK where he was a Senior Fellow. An accomplished drug discovery leader with a PhD from the University of Pennsylvania, he specializes in immunology and advancing drugs from target selection to clinical development.
Colleagues consistently describe him as a highly creative, dedicated, and accomplished drug discovery leader with a relentless drive to progress programs from initial identification through to clinical trials.
Unique Fact: During his tenure at GSK, he built a first-in-class immunology portfolio based on data from 23andMe genetics.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.